MYASTHENIA GRAVIS, GENERALIZED
Clinical trials for MYASTHENIA GRAVIS, GENERALIZED explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS, GENERALIZED trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, GENERALIZED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for seniors with rare muscle disease: Steroid-Free future?
Disease control Recruiting nowThis study looks at whether a drug called efgartigimod can help elderly patients (65 and older) with generalized myasthenia gravis lower their steroid doses. Steroids often cause serious side effects in older adults. The study will track 50 patients for 12 months to see if efgart…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated May 26, 2026 02:12 UTC
-
New drug trial aims to tame muscle weakness in myasthenia gravis
Disease control Recruiting nowThis study tests an experimental drug called povetacicept in about 30 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if the drug can safely lower certain immune proteins (IgG) and improve symptoms. Participants will receive …
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 26, 2026 02:11 UTC
-
New study tracks Real-World impact of ravulizumab on muscle weakness
Disease control Recruiting nowThis study follows 50 adults with generalized myasthenia gravis (gMG) who are starting ravulizumab, a drug that controls the immune system. Researchers will measure changes in daily activities like breathing, swallowing, and moving over time. The goal is to see how well the treat…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 02:06 UTC
-
New drug aims to ease muscle weakness in myasthenia gravis
Disease control Recruiting nowThis study tests a new drug called aritinercept in people with generalized myasthenia gravis, a condition that causes muscle weakness. The drug works by blocking two proteins that may drive the disease. Researchers want to see if it is safe and can improve daily activities. About…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE1, PHASE2 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Massive study aims to unlock secrets of brain inflammation diseases
Knowledge-focused Recruiting nowThis study collects health information from up to 10,000 people with conditions like Long COVID, ME/CFS, and autoimmune diseases. Participants use a phone app to share symptoms, wearables data, and lifestyle details. The goal is to help researchers better understand these illness…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC